[Pharmacologic therapy of bone tissue changes due to hematologic malignancies and bone metastasis].
Haematologic malignancies and solid tumors are often complicated by the bone tissue destruction. Neoplastic osteolysis and/or osteosclerosis occurs together with the disturbances of calcium and phosphorus metabolism. This paper updates the possibilities of a modern specific pharmacologic treatment of bone and mineral homeostasis changes caused by neoplasms.
Kiełbiński
M
M
Katedry i Kliniki Hematologii i Chorób Rozrostowych Krwi we Wrocławiu.
D001859:Bone Neoplasms / Q000556:secondary*; D002116:Calcitonin / Q000627:therapeutic use; D004002:Clodronic Acid / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D012968:Etidronic Acid / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D010014:Osteolysis / Q000188:drug therapy* / Q000209:etiology; D010026:Osteosclerosis / Q000188:drug therapy / Q000209:etiology; D000077268:Pamidronate
D004164:Diphosphonates; D004002:Clodronic Acid; D002116:Calcitonin; D012968:Etidronic Acid; D000077268:Pamidronate
Farmakologiczne leczenie zmian kostnych w przebiegu nowotoworów hematologicznych i w przerzutach do kości.